Sentences with phrase «in tumor imaging»
I am a dedicated research scientist with a PhD in Biomedical Engineering and post-graduation experience in developing optical devices for application in tumor imaging and point - of - care diagnosis.
http://members.climber.com/ Not exact matches
The first step in the process is to surgically remove the patient's tumor and ensure that the patient is cancer free by confirming that there is no sign of cancer on blood tests and imaging studies.
«We're trying to build models that describe how tumors grow and respond to therapy,» said Yankeelov, director of the Center for Computational Oncology at The University of Texas at Austin (UT Austin) and director of Cancer Imaging Research in the LIVESTRONG Cancer Institutes of the Dell Medical School.
«There was this initial thought that [circulating tumor cells] are only present at late stage,» says Sollier - Christen, but she notes that in the past year, several studies using more sensitive techniques have found such cells much earlier in tumor development, even before the tumor becomes visible by conventional imaging techniques.
«Particularly in such patients with underlying CKD, our modeling results support the integration of renal tumor anatomic features at cross-sectional imaging into decision making for treatment of small renal masses and may be used to provide a patient - centered framework for selection of optimal candidates for ablative therapy,» Kang said.
«We provide a framework for incorporating tumor imaging features and renal function into treatment selection, which may help to inform physicians regarding the appropriateness of surgery in patients with CKD,» Kang said.
In past imaging studies, my colleagues and I noticed that cervical tumors that took up a lot of glucose prior to radiation treatment tended to be more resistant to radiation therapy than other tumors.
EM: Imaging such as MRIs or CT scans, which reveal the mass and volume of the tumor, can fool you sometimes: The patient gets a scan, goes on a therapy, and when they return in a month for a second imaging, the structure and size of the tumor haven't cImaging such as MRIs or CT scans, which reveal the mass and volume of the tumor, can fool you sometimes: The patient gets a scan, goes on a therapy, and when they return in a month for a second imaging, the structure and size of the tumor haven't cimaging, the structure and size of the tumor haven't changed.
«Clearer vision of what's inside a tumor and what's going on in there: Researchers combine powerful imaging and metabolic analysis techniques to record disease events in high resolution.»
These results demonstrate that noninvasive imaging of EGFR activating mutation status in primary and metastatic tumors with 18F - MPG PET / CT is a valid strategy for stratifying NSCLC patients for EGFR - TKI treatment.
The first - in - human PET / CT imaging of 75 patients with 18F - MPG was performed to show that this tracer can be used as a companion diagnostic to identify NSCLC patients with EGFR activating mutant tumors (primary tumor or metastatic) with 84.3 % accuracy.
«With 18F - MPG PET / CT imaging, we were able to quantitate EGFR - activating mutation status in NSCLC patients (primary tumor or metastatic) and directly determine / visualize the location (s) and morphology of the NSCLCs.»
Scientists at Barrow Neurological Institute have recently made discoveries about use of a new technology for imaging brain tumors in the operating room — a finding that could have important implications for identifying and locating invading cells at the edge of a brain tumor.
Magnetic resonance imaging (MRI) has recently demonstrated glucose imaging in mouse tumors.
For example, just before von Eschenbach arrived, NCI had agreed to fund a now - $ 350 million screening trial to see if spiral computed tomography (CT) scans could detect lung tumors missed by x-ray imaging in former smokers.
To overcome these problems, Min and his team developed a new modality to visualize glucose uptake activity inside single cells based on stimulated Raman scattering (SRS) imaging, and demonstrated its use in live cancer cells, tumor xenograft tissues, primary neurons and mouse brain tissues.
In a study presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the bodyIn a study presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the bodyin the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F - fluorodeoxyglucose (FDG) PET / CT imaging to show that the amount of cell - free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the bodyin the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the bodyin the body).
«We synthesized an imaging probe that stays dark in normal tissues but switches on like a light bulb when it reaches solid tumors.
The next step, he added, is to prove the applicability of photoacoustic imaging in tumor models and ultimately in patients.
The MRI imaging detected metastatic tumors, including micrometastases, in lung, liver, lymph node, adrenal gland, bone, and brains of the mice.
Published in Nature Photonics, this work might lay a foundation for in vivo experiments that use light in biomedical imaging, optogenetics, tumor treatment, and for recharging implanted medical devices.
In their current study, described online today in Science, Discher and his colleagues copied short snippets of the CD47 protein, known as peptides, and attached them to nanoparticles designed to ferry either imaging agents or anticancer compounds to tumorIn their current study, described online today in Science, Discher and his colleagues copied short snippets of the CD47 protein, known as peptides, and attached them to nanoparticles designed to ferry either imaging agents or anticancer compounds to tumorin Science, Discher and his colleagues copied short snippets of the CD47 protein, known as peptides, and attached them to nanoparticles designed to ferry either imaging agents or anticancer compounds to tumors.
A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (Imaging (SNMMI).
In the mice with cancer, the probes enabled detailed, 3 - D ultrasound imaging of hypoxic tumors.
While on one hand, there is significant potential in the application of nanoparticles in enhancing heat transfer for tumor ablation and targeted drug delivery, there is also much promise in improving imaging and diagnostic protocols using them.
The technique is currently being tested in a number of clinical applications, including imaging breast tumors, detecting skin cancer, and tracking blood oxygenation in tissues.
They found that using the VASH collimator with an existing breast molecular imaging system, they could get six times better contrast of tumors in the breast, which could potentially reduce the radiation dose to the patient by half from the current levels, while maintaining the same or better image quality.
A newly devised tumor - specific fluorescent agent and imaging system guided surgeons in real time to remove additional tumors in ovarian cancer patients that were not visible without fluorescence or could not be felt during surgery, reports Alexander L. Vahrmeijer MD, PhD, head of the Image - guided Surgery group in the Department of Surgery at Leiden University Medical Center in the Netherlands.
«Novel imaging model helps reveal new therapeutic target for pancreatic cancer: Antisense treatment in preclinical models shows effectiveness against deadly tumors.»
Frangioni is also CEO of Curadel, a company he started in 2014 with the purpose of developing NIR contrast agents and imaging systems to help surgeons identify glands, blood vessels, nerves, lymph nodes, and tumors during operations.
• MRI imaging technology is to be used in specific situations, including for patients who have metastatic tumors, for detecting head and neck paragangliomas and for patients in whom radiation exposure should be limited; and
«This is really a big step forward in imaging brain tumors and other issues in young patients,» said Journal of Medical Imaging associate editor Christoph Hoeschen of Otto - von - Guericke Univeimaging brain tumors and other issues in young patients,» said Journal of Medical Imaging associate editor Christoph Hoeschen of Otto - von - Guericke UniveImaging associate editor Christoph Hoeschen of Otto - von - Guericke Universität.
The new method, described in a scientific paper that will be published Feb. 18 in The Lancet Oncology, is a modification of magnetic resonance imaging that employs a novel contrast agent to find tumors.
Researchers are rooting out these primary tumors, many of them found in the gastrointestinal tract or the lungs, with combined positron emission tomography and computed tomography (PET / CT), which provides both functional and structural imaging of the body.
• Another imaging technology, 18F - fluorodeoxyglucose - positron emission tomography / computed tomography, can be used in patients with metastatic tumors.
«If we can confirm that substantial signal levels originate from glucose in the cell interior, this would be important additional information for tumor imaging and functional MRI.
A further chemical modification in the ProCA32 MRI contrast agent improves the ability for the compound to be retained in blood for a longer period of time, permitting a longer window for imaging and tumor detection.
That would be a huge boon for therapy by allowing doctors to combine visual imaging, such as MRI scans, of tumors with knowledge of their genetic make - up, says experimental oncologist Janusz Rak of McGill University Health Centre in Montreal, Canada.
The increase in medical radiation exposure (from 0.53 mSv to 3.0 mSv) stemmed primarily from a rise in the use of computer tomography (CT) scans (which use x-rays to create cross sectional images of inside the body to spot tumors, clogged arteries, among other things), and nuclear imaging tests, which involve injecting radioactive chemicals into the bloodstream that can be picked up by special instruments and used to create images of the body's inner structures.
Scientists at Georgia State University (GSU) with funding from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have designed an imaging technique to detect early - stage liver tumors, and have proven it successful iImaging and Bioengineering (NIBIB) have designed an imaging technique to detect early - stage liver tumors, and have proven it successful iimaging technique to detect early - stage liver tumors, and have proven it successful in mice.
Regrowth or progression of tumor was defined as any increase in size of known residual tumor on follow - up radiographic imaging.
Baltimore, Md. (Embargoed until 12:30 pm EDT on Monday, June 8)-- A relatively new biomarker called prostate - specific membrane antigen (PSMA) is the bullseye for three new magnetic resonance imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (imaging (MRI) agents that bind to the protein in not only prostate cancer, but a range of tumor types, according to research unveiled at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (Imaging (SNMMI).
Can tumors be detected when they are two to three orders of magnitude smaller than those currently detected with in vivo imaging modalities?
«An appropriate pH imaging method would make it possible to visualize abnormal changes in tissue and specifically metabolic processes of tumors,» explains Franz Schilling.
They found that injecting into the carotid artery breast cancer cells that express markers allowing them to enter the brain — cells labelled with bioluminescent and fluorescent markers to enable tracking by imaging technologies — resulted in the formation of many metastatic tumors throughout the brain, mimicking what is seen in advanced breast cancer patients.
Emerging molecular imaging agents join tumor - seeking antibodies and signaling radioisotopes in one radiopharmaceutical that is injected at the time of imaging in order to track and report active receptors.
In an interview, Sharp said that to build new understanding of tumors or ecosystems, scientists must be able to analyze oceans of new data generated by genomic sequencing, imaging, and other advanced technology.
«Metastatic brain tumors — often from lung, breast or skin cancers — are the most commonly observed tumors within the brain and account for about 30 percent of advanced breast cancer metastases,» says Khalid Shah, MS, PhD, director of the Molecular Neurotherapy and Imaging Laboratory in the MGH Departments of Radiology and Neurology, who led the study.
In Vivo Imaging of siRNA Delivery and Silencing in TumorIn Vivo Imaging of siRNA Delivery and Silencing in Tumorin Tumors.
SNMMI NET Roadshow Advances in Nuclear Imaging and Therapy for Neuroendocrine Tumors August 24, 2017 Grand America Hotel Seattle, WA